Drug Free Solution, Inc.

Drug Free Solution, Inc.

DSOL
Drug Free Solution, Inc.US flagOther OTC
0.00
USD
- -
- -
88,891.00Market Cap
Drug Free Solution, Inc.
DSOL
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2012
2013
TTM
FRC
- -
- -
- -
Revenue per Share
-0.01
-0.01
-0.01
Basic EPS, GAAP
-0.01
-0.01
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
Dividend per Share
-0.01
-0.02
-0.02
Book Value per Share
- -
- -
- -
Tangible Book Value per Share
54
72
74
Basic Weighted Avg Shares
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
-41,299.95
Operating Margin (%)
- -
- -
- -
Depreciation Expense
-1
-1
-1
Net Income, GAAP
- -
- -
- -
Effective Tax Rate (%)
- -
- -
-41,299.95
Profit Margin (%)
- -
- -
- -
Working Capital
- -
- -
- -
LT Debt
- -
- -
- -
Total Equity
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
Return on Capital (%)
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Aug'14
Nov'14
Feb'14
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
86
36
36
Market Capitalization
15
19
20

Working Capital

FRC

in mil. unless spec.
Aug'14
Nov'14
Feb'14
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-353.63%
Free Cash Flow
- -
- -
9.86%
Net Income, GAAP
- -
- -
20.83%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2012
- -
- -
- -
- -
- -
2013
- -
- -
- -
- -
- -
2014
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2012
- -
- -
- -
- -
-0.01
2013
- -
- -
- -
- -
-0.01
2014
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2012
- -
- -
- -
- -
- -
2013
- -
- -
- -
- -
- -
2014
- -
- -
- -
- -
- -
Business
Drug Free Solution, Inc. (DSOL) operates as a lifestyle and healthcare company that delivers proprietary emotional wellness technology through its Living Breath Process, a three-step methodology combining self-analysis, breath techniques, and specialized language sequences; the company offers the Living Breath Series of programs encompassing products, education, services, and digital platforms such as Daily Feels (also referred to as Daily Feelz or Get Your Feelz On) targeting addiction prevention and recovery, self-help, emotional wellness, depression, stress-related anxiety, detoxification symptoms, and cognitive disorders. It further develops the Living Breath Project, which includes protocols, lifestyle enhancement products, training, and education aimed at establishing community wellness centers, wellness homes, and correctional facility support networks to reduce addiction and incarceration rates across the United States. Founded in 2011 by Genie O'Malley and headquartered in El Segundo, California, with some references to Balboa Island operations, the company serves individual consumers, communities, courts as alternative addiction treatment, and institutional markets in the U.S. healthcare information services and health care services sectors. In recent developments, Drug Free Solution, Inc. appointed Jessica Bass as Chief Executive Officer in February 2021, transitioning founder Genie O'Malley to Chairwoman of the Board to support growth and rollout strategies; the company was formerly known as Living Breath Project, Inc., changing its name in January 2014, and has pursued restructuring efforts including plans to reduce outstanding common shares while preparing online product launches such as expansions of its Daily Feels system.